Cordlife Group Ltd
SGX:P8A

Watchlist Manager
Cordlife Group Ltd Logo
Cordlife Group Ltd
SGX:P8A
Watchlist
Price: 0.15 SGD -0.66% Market Closed
Market Cap: 38.4m SGD
Have any thoughts about
Cordlife Group Ltd?
Write Note

Net Margin
Cordlife Group Ltd

-30.2%
Current
4%
Average
2.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-30.2%
=
Net Income
-11.1m
/
Revenue
36.6m

Net Margin Across Competitors

Country SG
Market Cap 38.4m SGD
Net Margin
-30%
Country US
Market Cap 78.1B USD
Net Margin
1%
Country US
Market Cap 74.5B EUR
Net Margin
1%
Country US
Market Cap 57.6B USD
Net Margin
1%
Country DE
Market Cap 25.5B EUR
Net Margin
3%
Country DE
Market Cap 18.9B EUR
Net Margin
-2%
Country US
Market Cap 19.2B USD
Net Margin
3%
Country US
Market Cap 17B USD
Net Margin
9%
Country DE
Market Cap 12.8B EUR
Net Margin
3%
Country US
Market Cap 12.6B USD
Net Margin
7%
Country AU
Market Cap 13.2B AUD
Net Margin
6%
No Stocks Found

Cordlife Group Ltd
Glance View

Market Cap
38.4m SGD
Industry
Health Care

Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.

P8A Intrinsic Value
0.26 SGD
Undervaluation 43%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-30.2%
=
Net Income
-11.1m
/
Revenue
36.6m
What is the Net Margin of Cordlife Group Ltd?

Based on Cordlife Group Ltd's most recent financial statements, the company has Net Margin of -30.2%.